INTERSTELLAR - International Study Evaluating Lupus Outcomes after Anifrolumab Real World Use

Trial Identifier: D3461R00072
Sponsor: AstraZeneca
Start Date: October 2024
Primary Completion Date: December 2027
Study Completion Date: December 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Argentina BUENOS AIRES, Argentina
Argentina CORDOBA, Argentina
China HONG KONG, China
China ZHONGSHAN, China
Costa Rica SAN JOSE, Costa Rica
Egypt ALEXANDRIA, Egypt
Egypt CAIRO, Egypt
Guatemala GUATEMALA, Guatemala
Kazakhstan AKTOBE, Kazakhstan
Kazakhstan PAVLODAR, Kazakhstan
Kazakhstan SEMEY, Kazakhstan
Kazakhstan SHYMKENT, Kazakhstan
Kuwait KUWAIT, Kuwait
Mexico MERIDA, Mexico
Mexico MEXICO CITY, Mexico
Oman MUSCAT, Oman
Qatar DOHA, Qatar
Saudi Arabia ASIR, Saudi Arabia
Saudi Arabia JEDDAH, Saudi Arabia
Saudi Arabia RIYADH, Saudi Arabia
Taiwan KAOHSIUNG, Taiwan
Taiwan TAIPEI, Taiwan
Taiwan TAOYUAN, Taiwan